[1] LYNNE M. KERR Doju Y. A venom peptide with a novel presynaptic blocking action[J]. Nature, 1984, 308 5956: 282-284. DOI:
10.1038/308282a0[2] E W MCCLESKEY. Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1987, 84 12: 4327-4331. DOI:
10.1073/pnas.84.12.4327[3] T J FEUERSTEIN W S D J Dooley. Inhibition of norepinephrine and acetylcholine release from human neocortex by omega-conotoxin GVIA.[J]. Journal of Pharmacology and Experimental Therapeutics, 1990, 252 2: 778-785.
[4] RICHARD A. LAMPE. Effects of site-specific acetylation on .omega.-conotoxin GVIA binding and function[J]. Biochemistry Biochemistry, 1993, 32 13: 3255-3260. DOI:
10.1021/bi00064a007[5] SATO K. Role of Basic Residues for the Binding of ω-Conotoxin GVIA to N-Type Calcium Channels[J]. Biochemical and biophysical research communications, 1993, 194 3: Pages 1292-1296. DOI:
10.1006/bbrc.1993.1964[6] R. A. KEITH. Characterization of the effects of ω-conotoxin GVIA on the responses of voltage-sensitive calcium channels[J]. Autonomic and Autacoid Pharmacology, 1989, 9 4: 243-252. DOI:
10.1111/j.1474-8673.1989.tb00215.x